1. Home
  2. AVTX vs PMVP Comparison

AVTX vs PMVP Comparison

Compare AVTX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • PMVP
  • Stock Information
  • Founded
  • AVTX 2011
  • PMVP 2013
  • Country
  • AVTX United States
  • PMVP United States
  • Employees
  • AVTX N/A
  • PMVP N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • AVTX Health Care
  • PMVP Health Care
  • Exchange
  • AVTX Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • AVTX 88.4M
  • PMVP 85.5M
  • IPO Year
  • AVTX 2015
  • PMVP 2020
  • Fundamental
  • Price
  • AVTX $7.79
  • PMVP $1.43
  • Analyst Decision
  • AVTX Strong Buy
  • PMVP Strong Buy
  • Analyst Count
  • AVTX 4
  • PMVP 3
  • Target Price
  • AVTX $33.00
  • PMVP $5.33
  • AVG Volume (30 Days)
  • AVTX 75.0K
  • PMVP 157.9K
  • Earning Date
  • AVTX 03-28-2025
  • PMVP 02-27-2025
  • Dividend Yield
  • AVTX N/A
  • PMVP N/A
  • EPS Growth
  • AVTX N/A
  • PMVP N/A
  • EPS
  • AVTX N/A
  • PMVP N/A
  • Revenue
  • AVTX $820,000.00
  • PMVP N/A
  • Revenue This Year
  • AVTX N/A
  • PMVP N/A
  • Revenue Next Year
  • AVTX N/A
  • PMVP N/A
  • P/E Ratio
  • AVTX N/A
  • PMVP N/A
  • Revenue Growth
  • AVTX N/A
  • PMVP N/A
  • 52 Week Low
  • AVTX $4.17
  • PMVP $1.32
  • 52 Week High
  • AVTX $34.46
  • PMVP $2.26
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 51.97
  • PMVP 47.66
  • Support Level
  • AVTX $7.08
  • PMVP $1.37
  • Resistance Level
  • AVTX $8.44
  • PMVP $1.46
  • Average True Range (ATR)
  • AVTX 0.83
  • PMVP 0.05
  • MACD
  • AVTX 0.20
  • PMVP 0.01
  • Stochastic Oscillator
  • AVTX 83.84
  • PMVP 78.57

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: